We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > pregabalin

News List

FDA Releases New Drug Safety Communication on Gabapentin, Pregabalin americanpharmaceuticalreview
December 23, 2019
The U.S. Food and Drug Administration (FDA) is warning that serious breathing difficulties may occur in patients using gabapentin (Neurontin, Gralise, Horizant) or pregabalin (Lyrica, Lyrica CR) ...
Gabapentin, Opioids a Deadly Duo: FDA drugs
December 20, 2019
New warnings about the risk of dangerous breathing difficulties when gabapentinoids are used with opioids or by certain patients must now appear on product labels ...
Epilepsy Drug Pregabalin (Lyrica) Tied to Higher Risk of Suicidal Behavior in Young Users drugs
June 14, 2019
Epilepsy Drug Pregabalin (Lyrica) Tied to Higher Risk of Suicidal Behavior in Young Users.
Pfizer loses landmark second medical use patent case pharmatimes
November 19, 2018
The UK Supreme Court has ruled against Pfizer in a long-running legal battle over the validity of a second medical use patent protecting pregabalin.